(Q46876266)
Statements
Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair (English)
Ireneusz Majsterek
Dariusz Pytel
Michal Kowalski